Matthew Albert

Matthew Albert

Auto-generated profile, based on publicly available information

Matthew Albert

Surgical Health Outcomes Consortium (SHOC) AdventHealth Digestive Health Institute Orlando Florida USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2023 in Updates in Surgery
Verified
Journal Article
Closed access
PDF file
LBL. Bustamante-Lopez
L. Bustamante-Lopez
MSM. Sulbaran
M. Sulbaran
NCN. R. Changoor
N. R. Changoor
YTY. Tilahun
Y. Tilahun
NGN. Garcia-Henriquez
N. Garcia-Henriquez
JPJulie Pepe
Julie Pepe

1 October 2024 in AME Case Reports
Verified
Journal Article
Open access
PDF file
MUMartin Uwah
Martin Uwah
LBLeonardo Bustamante-Lopez
Leonardo Bustamante-Lopez
LDLiam Devane
Liam Devane
JHJohn Hoff
John Hoff
NGNorbert Garcia-Henriquez
Norbert Garcia-Henriquez
MAMatthew Albert
Matthew Albert
Background: Idiopathic myointimal hyperplasia of the mesenteric veins (IMHMV) is a rare condition that poses a diagnostic challenge to surgeons and pathologists alike. Our aim is to describe two cases of IMHMV requiring operative intervention. The challenge going forward is accurately and systematically identifying factors from both a pathologic and clinical perspective that guide timely diagnosis and avoid unnecessary treatment. Case Description: A 37-year-old male with no significant past medical history was evaluated for a two-month history of abdominal pain, constipation, diarrhea and recent bleeding per rectum. Computed tomography (CT) scan revealed abnormal wall thickening with surrounding inflammatory changes and mesenteric edema involving the descending and sigmoid colon as well as the rectum. The patient was taken to the operating room where he underwent a laparoscopic-assisted extended left colectomy with end colostomy. The patient did well postoperatively and was ultimately meeting all goals for discharge by postoperative day 9. A 49-year-old male with a past medical history of hypertension, gastroesophageal reflux and recent coronavirus disease 2019 (COVID-19) infection was admitted to another hospital following several months of colitis of unknown etiology; unresponsive to antibiotics and steroids. CT scan revealed concentric, severe mural thickening and intramural edema of the distal descending colon extending to the rectum consistent with proctocolitis. The patient was taken to the operating room where he underwent a laparoscopic-assisted low anterior resection with end colostomy with findings of an extremely indurated, thickened left colon and rectum. The patient recovered from these additional interventions and was discharged home in stable condition on postoperative day 32. Conclusions: A multidisciplinary team approach to this condition will be vital to administering the appropriate treatment modalities for future cases of IMHMV.

11 November 2026 in Surgical Endoscopy
Verified
Journal Article
Open access
PDF file
MAMatthew Albert
Matthew Albert
TLTimothy B. Lautz
Timothy B. Lautz
AAAhmed Allawi
Ahmed Allawi
LCLauren Cobb
Lauren Cobb
SGSeth D. Goldstein
Seth D. Goldstein
PSPatricia Sylla
Patricia Sylla
Background: This phase III, multicenter, randomized, open-label study (NCT05754333) evaluated pudexacianinium chloride (ASP5354), a novel near-infrared fluorescence (NIR-F) imaging agent, for intraoperative ureter identification in minimally invasive and open abdominopelvic surgeries. Methods: Patients with normal renal function, mild renal impairment, or patients with moderately impaired renal function received one intravenous dose of pudexacianinium 3 mg intraoperatively. Investigators scored ureter conspicuity under white light (WL) or (WL+)NIR-F using a validated 5-point Likert scale. Primary and key secondary endpoints included intra-participant differences in conspicuity scores for WL versus (WL+)NIR-F, supported by blinded central image review and quantitative contrast enhancement factor (CEF) analysis. Results: Adults with normal renal function or mild renal impairment were randomly assigned in a 5:1 ratio to WL+NIR-F arm (intent-to-treat population, n = 72 [median age 55.0 years; 68.1% female]) or to WL-only arm ( n = 13 [median age 64.0 years; 76.9% female]). Eight adults with moderate renal impairment (median age 70.0 years; 75.0% female) and 14 adolescents with normal renal function or mild renal impairment (median age 14.5 years; 57.1% female) were imaged under WL+NIR-F (no randomization). In the same participants of intent-to-treat population, (WL+)NIR-F yielded significantly higher conspicuity scores than WL, both 30 min (± 15) postdose and at end of surgery, confirmed by central review and CEF analysis. Benefits persisted to 210 min post-injection (timepoints with ≥ 5 evaluable patients). No drug-related serious adverse events occurred, and most treatment-emergent adverse events were mild- or moderate-grade. Adults with moderate renal impairment had higher mean plasma pudexacianinium concentrations and slower urinary excretion than adults with normal renal function or mild renal impairment. Adolescents had numerically lower mean urine production rates and higher mean urine pudexacianinium concentrations than adults. Conclusions: Pudexacianinium is an effective visualization agent without invasive instrumentation. NIR-F imaging with pudexacianinium enhances ureter identification compared with WL-only, which may reduce risk of intraoperative ureter injury.

20 October 2026 in Colorectal Disease
Verified
Journal Article
Closed access
LKLampros Karakozis
Lampros Karakozis
MAMichael Abdelmasseh
Michael Abdelmasseh
MSMark Soliman
Mark Soliman
MAMatthew Albert
Matthew Albert
JKJustin Kelly
Justin Kelly
CAChristopher Thomas Aquina
Christopher Thomas Aquina